Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dabomb Protein BiotechROCO:6578 -1.92%57 5-Year Yield-on-Cost % is 2.19 as of Aug. 15, 2026, which is 12% below its 10-year median of 2.49. GuruFocus rates ROCO:6578 with a GF Score™ of 57/100 and a GF Value™ of NT$16.49 (Fairly Valued). The stock has 1 warning sign investors should review. Among 1,161 Consumer Packaged Goods companies, Dabomb Protein Biotech ranks worse than 65.2% on this metric.
Dabomb Protein Biotech's yield on cost for the quarter that ended in Mar. 2026 was 2.19.
The historical rank and industry rank for Dabomb Protein Biotech's 5-Year Yield-on-Cost % or its related term are showing as below:
ROCO:6578'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.8 Med: 2.49 Max: 6.95
Current: 2.19
During the past 13 years, Dabomb Protein Biotech's highest Yield on Cost was 6.95. The lowest was 0.80. And the median was 2.49.
ROCO:6578's 5-Year Yield-on-Cost % is ranked worse than 65.2% of 1161
companies
in the Consumer Packaged Goods industry
Industry Median: 3.42
vs ROCO:6578: 2.19
Dabomb Protein Biotech (ROCO:6578) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Dabomb Protein Biotech 5-Year Yield-on-Cost % Related Terms
ROCO:6578 vs KHC, GIS: 5-Year Yield-on-Cost % Comparison
For the Packaged Foods subindustry, Dabomb Protein Biotech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dabomb Protein Biotech 5-Year Yield-on-Cost % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dabomb Protein Biotech's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Dabomb Protein Biotech's 5-Year Yield-on-Cost % falls into.
Dabomb Protein Biotech 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Dabomb Protein Biotech (ROCO:6578) has a 5-Year Yield-on-Cost % of 2.19 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dabomb Protein Biotech and its competitors. This is 12% below median its historical median of 2.49. Over the past decade, Dabomb Protein Biotech's 5-Year Yield-on-Cost % has ranged from 0.80 to 6.95. According to the industry distribution chart, Dabomb Protein Biotech ranks #757 out of 1161 companies in the Consumer Packaged Goods industry, placing it in the top 65.2%.
Is Dabomb Protein Biotech's 5-Year Yield-on-Cost % too high?
Dabomb Protein Biotech's current 5-Year Yield-on-Cost % of 2.19 is 12% below median its 10-year median of 2.49. Over the past 10 years, this metric has ranged from a low of 0.80 to a high of 6.95. The Consumer Packaged Goods industry median 5-Year Yield-on-Cost % is 3.42. Dabomb Protein Biotech's value of 2.19 is 36% below this industry median. Based on the distribution chart, Dabomb Protein Biotech ranks #757 out of 1161 companies in the Consumer Packaged Goods industry, which is below the industry midpoint. Overall, Dabomb Protein Biotech has a GF Score™ of 57/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Dabomb Protein Biotech's 5-Year Yield-on-Cost % compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Dabomb Protein Biotech ranks #757 out of 1161 companies for 5-Year Yield-on-Cost %. This places Dabomb Protein Biotech in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.42. Dabomb Protein Biotech's value of 2.19 is 36% below this benchmark. Historically, Dabomb Protein Biotech's own 5-Year Yield-on-Cost % has ranged from 0.80 to 6.95 over the past decade. While the company's 10-year median is 2.49 vs. the industry median of 3.42, Dabomb Protein Biotech has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Consumer Packaged Goods company?
The median 5-Year Yield-on-Cost % among Consumer Packaged Goods companies is 3.42, based on 1,161 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dabomb Protein Biotech's current 5-Year Yield-on-Cost % of 2.19 is 36% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Dabomb Protein Biotech and its competitors. For the Consumer Packaged Goods industry, the median 5-Year Yield-on-Cost % is 3.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dabomb Protein Biotech's current 5-Year Yield-on-Cost % is 2.19, which is 12% below median its own 10-year median of 2.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dabomb Protein Biotech stock overvalued right now?
Based on GuruFocus' analysis, Dabomb Protein Biotech (ROCO:6578) is currently considered Fairly Valued. The stock's GF Value™ is NT$16.49, compared to a current price of NT$17.90 — trading 8.6% above its estimated fair value. The current 5-Year Yield-on-Cost % is 2.19, which is 12% below median its 10-year median of 2.49 and 36% below the Consumer Packaged Goods industry median of 3.42. Dabomb Protein Biotech's overall GF Score™ is 57/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Dabomb Protein Biotech (ROCO:6578), the current 5-Year Yield-on-Cost % is 2.19 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dabomb Protein Biotech (ROCO:6578) Overvalued in 2026?
Based on GuruFocus' analysis, Dabomb Protein Biotech stock appears to be overvalued.
The current stock price of NT$17.90 is trading 8.6% above its estimated GF Value™ of NT$16.49.
GuruFocus considers Dabomb Protein Biotech to be Fairly Valued.
Key valuation signals for ROCO:6578:
5-Year Yield-on-Cost %: 2.19 (12% below median its 10-year median of 2.49)
GF Value™: NT$16.49 vs. price of NT$17.90 (8.6% above fair value)
Industry Position: 36% below the Consumer Packaged Goods median (#757 of 1161)
No single metric tells the full story. See the ROCO:6578 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. The products of the company include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). The company operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, Vietnam, and Others with majority of the revenue deriving from Vietnam.
57GF Score
Get the complete analysis for ROCO:6578
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6578 has been successfully added to your 
